ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs
The content of this joint guidance was developed by the European Centre for Disease Prevention and Control (ECDC) and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with the support of a technical advisory group composed of policy makers, service providers, civil society representatives and preventative health experts from throughout the EU/EEA.
ECDC and EMCDDA technical guidance on prevention and control of infectious diseases among people who inject drugs - guidance in brief
This evidence-based guidance is designed to inform the development, monitoring and evaluation of national strategies and programmes in countries in Europe in order to reduce and prevent infections among people who inject drugs.
Rapid Risk Assessment: Potential public health risks related to communicable diseases at the WorldPride festival in Madrid, 23 June–2 July 2017
This rapid risk assessment reviews the health risks related to communicable diseases in the context of the WorldPride festival in Madrid, from 23 June to 2 July 2017.
Rapid risk assessment: Public health risks related to communicable diseases during the hajj 2019, Saudi Arabia, 9–14 August 2019
In 2019, the hajj will take place between 9 and 14 August. The risk for EU/EEA citizens to become infected with communicable diseases during the 2019 hajj is considered low, thanks to the vaccination requirements for travelling to Makkah (Mecca) and the Saudi Arabian preparedness plans that address the management of health hazards during and after hajj.
- Food- and waterborne diseases
- Hepatitis A
- Hepatitis B
- Mass gathering
- Meningococcal disease
- Middle East respiratory syndrome coronavirus
- Public health threat
- Saudi Arabia
- Travellers' health
- Vaccine preventable diseases
- Vector-borne disease
Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review
Hofstraat, S.H.I., Falla, A.M., Duffell, E.F., Hahné, S.J.M., Amato-Gauci, A.J., Veldhuijzen, I.K., Tavoschi, L.
HIV testing in Europe: Evaluating the impact, added value, relevance and usability of the European centre for disease prevention and control (ECDC)’s 2010 HIV testing guidance
Sullivan, A.K., Sperle, I., Raben, D., Amato-Gauci, A.J., Lundgren, J.D., Yazdanpanah, Y., Jakobsen, S.F., Tavoschi, L.
PRECEPT: An evidence assessment framework for infectious disease epidemiology, prevention and control
Harder, T., Takla, A., Eckmanns, T., Ellis, S., Forland, F., James, R., Meerpohl, J.J., Morgan, A., Rehfuess, E., Schünemann, H., Zuiderent-Jerak, T., De Carvalho Gomes, H., Wichmann, O.
Prevention and assessment of infectious diseases among children and adult migrants arriving to the European Union/European Economic Association: A protocol for a suite of systematic reviews for public health and health systems
Pottie, K., Mayhew, A.D., Morton, R.L., Greenaway, C., Akl, E.A., Rahman, P., Zenner, D., Pareek, M., Tugwell, P., Welch, V., Meerpohl, J., Alonso-Coello, P., Hui, C., Biggs, B.-A., Requena-Méndez, A., Agbata, E., Noori, T., Schünemann, H.J.